Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

October 31, 1999

Primary Completion Date

September 30, 2001

Study Completion Date

September 30, 2001

Conditions
Head and Neck Cancer
Interventions
DRUG

Trastuzumab

Trial Locations (10)

13905

Lourdes Regional Cancer Center, Binghamton

19111

Fox Chase Cancer Center, Philadelphia

34952

Hematology/Oncology Associates, Port Saint Lucie

63110

Washington University Barnard Cancer Center, St Louis

06504

Yale-New Haven Hospital, New Haven

02114

Massachusetts General Hospital Cancer Center, Boston

02115

Dana-Farber Cancer Institute, Boston

02601

Cape Cod Health Care, Hyannis

02554

Nantucket Cottage Hospital, Nantucket

77030-4009

University of Texas - MD Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Genentech, Inc.

INDUSTRY

lead

Dana-Farber Cancer Institute

OTHER